Incidence, Impact and Mechanisms of Perioperative Right VEntricular Dysfunction (IMPRoVE)

NCT ID: NCT05827315

Last Updated: 2023-04-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

175 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-04-30

Study Completion Date

2026-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A study to see how common right heart failure (right ventricular dysfunction) after major surgery is, and to investigate if right ventricular dysfunction causes worse patient outcomes after surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Heart attacks are relatively rare around the time of surgery, however by measuring blood markers of heart injury, recent research has revealed that heart injury which otherwise may not be immediately obvious is common. Whilst this type of heart injury appears to be strongly linked to patient outcomes (complications, recovery and survival), the causes and potential treatments for it are not well understood.

Our research group has specialist knowledge about the right-hand side of the heart (right-heart) - the side that pumps blood through the lungs - which is less commonly considered or studied around the time of surgery. We have shown in previous studies using magnetic resonance imaging (MRI) scans (specialised whole-body scans which use a magnet rather than X-rays), evidence of right-heart function deteriorating after surgery. We want to test the idea that some of the blood marker evidence of heart injury reflects injury to the right-heart and more importantly that we can protect the right-heart around the time of surgery, reducing injury and improving patient outcomes.

We will examine these questions in the following ways:

1. With patients' permission, we will perform detailed ultrasound scans of the heart (echocardiography), and blood measurement of injury markers in 175 patients undergoing different types of major surgery. This will allow us to assess how common heart injury is (visible on scans of both sides of the heart), whether it makes any difference to a patient's outcome and whether it explains the changes seen in blood markers.
2. We will ask 50 of these patients to undergo MRI scans of the heart pre- and post-operatively to allow us to identify evidence of injury resulting from heart inflammation around the time of surgery. Inflammation is common following surgery and occurs throughout a patient's body - we believe heart inflammation may be responsible for postoperative heart injury.
3. In 10 of these patients, we will seek to obtain blood samples from vessels flowing into the heart (easily obtained from a simple blood sample) and from veins flowing out of the heart, obtained by passing a fine tube into the heart via blood vessels in a patient's neck under X-ray guidance. This will allow us to examine what happens to immune cells as they pass through the heart (i.e., are they activated by heart inflammation?) and better understand the meaning of the changes seen on MRI scans.

This study will give us a better understanding of which patients are likely to suffer heart injury around the time of surgery and how this injury occurs. With this knowledge, future patients could receive personalised treatment plans aimed at preventing injury and improving outcomes. We are not testing any new treatments in this study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Right Ventricular Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Thoracic surgery cohort

35 patients undergoing thoracic surgery with lung resection and one lung ventilation under primarily general anaesthesia.

Echocardiography

Intervention Type DIAGNOSTIC_TEST

Echocardiography will be performed by BSE accredited echocardiographers in all 175 patients preoperatively and on day 2-4 postoperatively.

T1 Cardiovascular Magnetic Resonance

Intervention Type DIAGNOSTIC_TEST

T1 CMR will be performed in 10 patients from each of the 5 surgical groups (50 patients in total) preoperatively and on day 2-4 postoperatively.

Right heart catheterisation and coronary sinus blood sampling

Intervention Type DIAGNOSTIC_TEST

10 patients from the thoracic surgical group will undergo right heart catheterisation and coronary sinus blood sampling.

Upper gastrointestinal surgery cohort

35 patients undergoing upper gastrointestinal surgery with one lung ventilation under primarily general anaesthesia.

Echocardiography

Intervention Type DIAGNOSTIC_TEST

Echocardiography will be performed by BSE accredited echocardiographers in all 175 patients preoperatively and on day 2-4 postoperatively.

T1 Cardiovascular Magnetic Resonance

Intervention Type DIAGNOSTIC_TEST

T1 CMR will be performed in 10 patients from each of the 5 surgical groups (50 patients in total) preoperatively and on day 2-4 postoperatively.

Colorectal surgery cohort

35 patients undergoing elective colorectal surgery under primarily general anaesthesia.

Echocardiography

Intervention Type DIAGNOSTIC_TEST

Echocardiography will be performed by BSE accredited echocardiographers in all 175 patients preoperatively and on day 2-4 postoperatively.

T1 Cardiovascular Magnetic Resonance

Intervention Type DIAGNOSTIC_TEST

T1 CMR will be performed in 10 patients from each of the 5 surgical groups (50 patients in total) preoperatively and on day 2-4 postoperatively.

Vascular surgery cohort

35 patients undergoing elective open abdominal aortic surgery under primarily general anaesthesia.

Echocardiography

Intervention Type DIAGNOSTIC_TEST

Echocardiography will be performed by BSE accredited echocardiographers in all 175 patients preoperatively and on day 2-4 postoperatively.

T1 Cardiovascular Magnetic Resonance

Intervention Type DIAGNOSTIC_TEST

T1 CMR will be performed in 10 patients from each of the 5 surgical groups (50 patients in total) preoperatively and on day 2-4 postoperatively.

Orthopaedic surgery cohort

35 patients undergoing elective primary hip or knee arthroplasty under spinal anaesthesia +/- sedation.

Echocardiography

Intervention Type DIAGNOSTIC_TEST

Echocardiography will be performed by BSE accredited echocardiographers in all 175 patients preoperatively and on day 2-4 postoperatively.

T1 Cardiovascular Magnetic Resonance

Intervention Type DIAGNOSTIC_TEST

T1 CMR will be performed in 10 patients from each of the 5 surgical groups (50 patients in total) preoperatively and on day 2-4 postoperatively.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Echocardiography

Echocardiography will be performed by BSE accredited echocardiographers in all 175 patients preoperatively and on day 2-4 postoperatively.

Intervention Type DIAGNOSTIC_TEST

T1 Cardiovascular Magnetic Resonance

T1 CMR will be performed in 10 patients from each of the 5 surgical groups (50 patients in total) preoperatively and on day 2-4 postoperatively.

Intervention Type DIAGNOSTIC_TEST

Right heart catheterisation and coronary sinus blood sampling

10 patients from the thoracic surgical group will undergo right heart catheterisation and coronary sinus blood sampling.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Provision of informed consent
2. Age \>18 years
3. Planned elective primary hip or knee joint replacement under spinal anaesthesia, major colorectal, major vascular surgery or surgery requiring one lung ventilation with or without lung resection

Exclusion Criteria

1. Pregnancy
2. On-going participation in any investigational research which could undermine the scientific basis of the study
3. Previous major surgery within three months prior to recruitment
4. Previous participation in the IMPRoVE study at any time
5. Inadequate comprehension of English resulting in inability to comply with instructions while undergoing investigations required for main study and sub-studies.


1. Atrial fibrillation at baseline
2. Contraindication to cardiac magnetic resonance imaging (metal work in body etc)
3. Contraindication to IV Gadolinium: acute or chronic renal failure, allergy to contrast
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Glasgow

OTHER

Sponsor Role collaborator

NHS Greater Glasgow and Clyde

OTHER

Sponsor Role collaborator

Royal London Hospital

UNKNOWN

Sponsor Role collaborator

NHS National Waiting Times Centre Board

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr Ben Shelley

Honorary Professor/Consultant in Cardiothoracic Anaesthesia and Intensive Care

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ben Shelley

Role: PRINCIPAL_INVESTIGATOR

National Waiting Times Centre Board

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Golden Jubilee National Hospital

Clydebank, , United Kingdom

Site Status

Glasgow Royal Infirmary

Glasgow, , United Kingdom

Site Status

Queen Elizabeth University Hospital

Glasgow, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ben Shelley

Role: CONTACT

0141 951 5000

Philip McCall

Role: CONTACT

0141 951 5000

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ben Shelley

Role: primary

0141 9515000 ext. 4293

Rachel Kearns

Role: primary

0141 211 4000

Malcolm Watson

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Keast T, McErlane J, Kearns R, McKinlay S, Raju I, Watson M, Robertson KE, Berry C, Greenlaw N, Ackland G, McCall P, Shelley B. Study protocol for IMPRoVE: a multicentre prospective observational cohort study of the incidence, impact and mechanisms of perioperative right ventricular dysfunction in non-cardiac surgery. BMJ Open. 2023 Sep 6;13(9):e074687. doi: 10.1136/bmjopen-2023-074687.

Reference Type DERIVED
PMID: 37673452 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

22/ANAES/06

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.